Clinical Trials Directory

Trials / Completed

CompletedNCT02139826

Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men

A Randomised, Single-dose, 3-way Crossover Study to Evaluate the Relative Bioavailability of the IX-01 Capsule Formulation Compared With the IX-01 Aqueous Dispersion Formulation, and the Effect of Food on the IX-01 Capsule Formulation, in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Ixchelsis Limited · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare the absorption and blood levels of IX-01 when given as a capsule compared to liquid form, and how food affects the absorption in healthy men.

Conditions

Interventions

TypeNameDescription
DRUGIX-01

Timeline

Start date
2014-05-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2014-05-15
Last updated
2020-08-20
Results posted
2020-08-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02139826. Inclusion in this directory is not an endorsement.